Clinical and commercial batches
- Release testing is the final checkpoint prior clearance of a drug product for clinical studies or commercial distribution, ensuring it meets the strict specifications registered with authorities (EMA, FDA).
- Certificate of Analysis (CoA) is provided in line with GMP standards, including e.g. batch identifier, testing results, pass/fail evaluation and QC responsible approval.